Robinson Wins Best New Paper at Central Surgical Association
Bryce Robinson, MD, assistant professor of surgery, division of trauma and critical care, won the 2014 Best New Member Paper award at the
Annual Meeting, held March 6-8 in Indianapolis.
Robinsons paper was titled, "Cost Discrepancies for Common General Surgery Diagnoses in Ohio: Implication of Hospital Characteristics for Charge and Payment Differences.
The UC Department of Surgery had four scientific presentations at the meeting as well as several faculty moderators.
Presentations include:
- "High Readmission Rates Following Surgery for Chronic Pancreatitis, by AV Fisher, JM Sutton, GC Wilson, DJ Hanseman, DE Abbott, MT Smith, N Schmulewitz, KA Choe, J Wang, JJ Sussman, and SA Ahmad.
- "Rising Incidence of NASH as an Indication for Liver Transplantation, RC Quillin MD, GC Wilson MD, JM Sutton MD, DJ Hanseman PhD, F Paterno MD, MC Cuffy MD, IM Paquette MD, TS Diwan MD, ES Woodle MD, DE Abbott MD, SA Shah MD.
- "Hospital Utilization and Consequences of Readmission After Liver Transplantation, F Paterno MD, GC Wilson MD, K Wima MS, RC Quillin MD, DE Abbott MD, MC Cuffy MD, T Diwan MD, TE Kaiser PharmD, ES Woodle MD, SA Shah MD.
- "Cost Discrepancies for Common General Surgery Diagnoses in Ohio: Implication of Hospital Characteristics for Charge and Payment Differences. BR Robinson MD, TA Pritts MD PhD, DH Hanseman PhD, DE Abbott MD .
Additionally, professor of surgical oncology Elizabeth Shaughnessy, MD, PhD, and associate professor of vascular surgery Joseph Giglia, MD, served as case presentation panelists and associate professor of surgery Timothy Pritts, MD, PhD, moderated a scientific session.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.